336 related articles for article (PubMed ID: 38476263)
1. Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer.
Zhang D; Chen H; Wang J; Ji J; Imam M; Zhang Z; Yan S
Front Cell Dev Biol; 2024; 12():1338448. PubMed ID: 38476263
[TBL] [Abstract][Full Text] [Related]
2. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
[TBL] [Abstract][Full Text] [Related]
3. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A
Gene; 2023 Aug; 877():147548. PubMed ID: 37279863
[TBL] [Abstract][Full Text] [Related]
4. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
5. Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells.
Cirillo F; Spinelli A; Talia M; Scordamaglia D; Santolla MF; Grande F; Rizzuti B; Maggiolini M; Gérard C; Lappano R
J Transl Med; 2024 May; 22(1):450. PubMed ID: 38741146
[TBL] [Abstract][Full Text] [Related]
6. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
[TBL] [Abstract][Full Text] [Related]
7. High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes.
Xu T; Ma D; Chen S; Tang R; Yang J; Meng C; Feng Y; Liu L; Wang J; Luo H; Yu K
NPJ Breast Cancer; 2022 Aug; 8(1):100. PubMed ID: 36042244
[TBL] [Abstract][Full Text] [Related]
8. GPER-regulated lncRNA-Glu promotes glutamate secretion to enhance cellular invasion and metastasis in triple-negative breast cancer.
Yin J; Tu G; Peng M; Zeng H; Wan X; Qiao Y; Qin Y; Liu M; Luo H
FASEB J; 2020 Mar; 34(3):4557-4572. PubMed ID: 32030797
[TBL] [Abstract][Full Text] [Related]
9. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-Related Receptor α (ERRα) and G Protein-Coupled Estrogen Receptor (GPER) Synergistically Indicate Poor Prognosis in Patients with Triple-Negative Breast Cancer.
Ye S; Xu Y; Wang L; Zhou K; He J; Lu J; Huang Q; Sun P; Wang T
Onco Targets Ther; 2020; 13():8887-8899. PubMed ID: 33061416
[TBL] [Abstract][Full Text] [Related]
11. G-Protein Coupled Estrogen Receptor in Breast Cancer.
Hsu LH; Chu NM; Lin YF; Kao SH
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646517
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Actions in Triple-Negative Breast Cancer.
Treeck O; Schüler-Toprak S; Ortmann O
Cells; 2020 Oct; 9(11):. PubMed ID: 33114740
[TBL] [Abstract][Full Text] [Related]
13. GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer.
Molina L; Figueroa CD; Bhoola KD; Ehrenfeld P
Expert Opin Ther Targets; 2017 Aug; 21(8):755-766. PubMed ID: 28671018
[TBL] [Abstract][Full Text] [Related]
14. GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway.
Cirillo F; Talia M; Santolla MF; Pellegrino M; Scordamaglia D; Spinelli A; De Rosis S; Giordano F; Muglia L; Zicarelli A; Di Dio M; Rigiracciolo DC; Miglietta AM; Filippelli G; De Francesco EM; Belfiore A; Lappano R; Maggiolini M
Cell Death Discov; 2023 Sep; 9(1):353. PubMed ID: 37749101
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P
Dis Markers; 2023; 2023():8371623. PubMed ID: 36741908
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status.
Ye S; Xu Y; Li J; Zheng S; Sun P; Wang T
Endocr Connect; 2019 Jun; 8(6):661-671. PubMed ID: 30999280
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple-negative breast cancer by 17β-estradiol.
Girgert R; Emons G; Gründker C
Oncol Lett; 2018 Jun; 15(6):9559-9566. PubMed ID: 29805678
[TBL] [Abstract][Full Text] [Related]
19. NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.
Wang Y; Peng Z; Meng R; Tao T; Wang Q; Zhao C; Liu H; Song R; Zheng J; Qin Q; He J
Oncol Rep; 2017 Jul; 38(1):221-228. PubMed ID: 28535016
[TBL] [Abstract][Full Text] [Related]
20. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.
Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS
Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
